When examining the influence of IDH1 mutation status, there were no significant differences in mean CSF BDNF levels between patients with GBM who had the IDH-mutant or IDH-wildtype variant (5.59 pg/mL versus 6.4 pg/mL) (p=1). This evidence concerns the gene IDH1 and glioblastoma.